Global Opioid Use Disorder Market is estimated to be valued at US$ 2,739.2 million in 2021 and is expected to exhibit a CAGR of 8.7% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Increasing involvement of government and non-government agencies is driving growth of the opioid use disorder market. Moreover, the growing number of individuals suffering from opioid addiction has significantly increased, and it has compelled governments to get involved on a wider scale to manage this crisis.
Click Here for Sample Copy (Use corporate email ID Get Higher Priority) @ https://www.coherentmarketinsights.com/insight/request-sample/4597
For instance, the U.S. has one of the largest pools of patients suffering from opioid dependency. This led the U.S. Department of Health and Human Services in 2017, to declare the opioid crisis as a public health emergency. Hence, for tackling this epidemic, the U.S. Department of Health and Human Services issued a five point strategy to combat the problem. These initiatives are projected to augment the number of individuals suffering from the increasing consumption of opioid induced drugs to opt for treatment. Such factors are expected to positively impact the global opioid use disorder market during the forecast period.
Global Opioid Use Disorder Market – Impact of Coronavirus (Covid-19) Pandemic
The COVID-19 has been declared as a pandemic by World Health Organization (WHO) due to its increased spread across the globe. The virus has spread to all continents from North America, Europe, Middle East and Africa and Asia-Pacific to Latin America. After the declaration of the pandemic, several nations such as the U.S., Germany, India, and China among others declared full lockdown in order to limit its spread. Owing to increasing cases of COVID-19, the pandemic related restrictions placed also increased the need for opioid abuse services as the fragmented drug supply chain created a shortage of availability. According to the UN Office on Drugs and Violence, approximately there are around 35 million opioid users worldwide (UNODC) in 2019. According to the World Health Organization (WHO) report globally and 201.8 million patients are infected with coronavirus. The outbreak of COVID-19 is causing untold health challenges especially on the vulnerable drug addict population having huge impact on the healthcare industry majorly for the opioid use disorder market.
The COVID-19 pandemic has lifted the opioid use disorder industry from its niche pedestal to the mainstream sector. The outbreak of COVID-19 pandemic has further expanded the role of drug addiction treatment due to well spread awareness regarding weakening of immunity and cardiovascular system due to excessive drug consumption. In long run, the COVID-19 pandemic has the potential to profoundly transform the drug market. Several companies operating in the domain are working to develop an opioid substitution therapy and other medication and some have already entered the landscape of the opioid use disorder market to increase their revenue by meeting the emergent need of sustainable and reliable therapies.
For More Information or Query or Customization before Buying, Visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/4597
For instance, in the U.S., during July 2020, federal government made law transformations to make the addiction treating drug naloxone accessible during the pandemic. U.S. FDA made amendments for the manufacturers to upgrade their respective package inserts and add on naloxone associated recommendations.
Key players operating in the market are focusing on product launches which is expected to drive the market growth over the forecast period. For instance, in February 2019, Dr. Reddy’s Laboratories, a pharmaceutical company announced the re-launch of its buprenorphine and naloxone sublingual film after the company received a favourable ruling in patent litigation.
Key Takeaways of the Global Opioid Use Disorder Market:
- The opioid use disorder market is expected to exhibit a CAGR of 8.7% over the forecast period, due to robust and diversified product portfolio of key players such as Indivior PL, Alkermes, and others.
- Among drug class, buprenorphine segment accounted for the largest market share in 2020, due to high adoption of these drugs across developed U.S. and France, along with the presence of several branded products market under this segment. Some essential buprenorphine products include SUBLOCADE, SUBOXONE and ZUBSOLV.
- Key players operating in the global opioid use disorder market are Indivior PLC, Alkermes, Orexo AB, Titan Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, BioDelivery Sciences International Inc., Viatris Inc., Pfizer, Inc., Hikma Pharmaceuticals PLC, and Camurus.
Up-To Avail 30% Discount on various license types on immediate purchase (Use corporate email ID Get Higher Priority) @ https://www.coherentmarketinsights.com/promo/buynow/4597
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Pipeline Analysis
- PEST Analysis
- Epidemiology
- Regulatory Scenario
- Reimbursement Scenario
- Acquisitions and Collaboration
- Brand Analysis
- Market Dynamics
- Global Opioid Use Disorder Market – Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Opioid Use Disorder Market
- Impact on Drug Development
- Global Opioid Use Disorder Market, By Drug Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Buprenorphine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Methadone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Naltrexone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Opioid Use Disorder Market, By Route of Administration, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Opioid Use Disorder Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/opioid-use-disorder-market-3845
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837